Rationale Mitral valve prolapse (MVP) is a common valve disease that leads to mitral
insufficiency, heart failure and sudden death. The identification of risk loci provided insight …

Rationale: Mitral valve prolapse (MVP) is a common valvopathy that leads to mitral
insufficiency, heart failure, and sudden death. Functional genomic studies in mitral valves …

Background: Mitral valve prolapse (MVP) is a common cardiac valve disease, which affects
1 in 40 in the general population. Previous genome-wide association study has identified 6 …

Nonsyndromic mitral valve prolapse (MVP) is a common degenerative valvulopathy of
unknown aetiology that predisposes to heart failure and sudden death. Here we investigate …

Aims Mitral valve prolapse (MVP) is a common valvular heart disease with a prevalence of>
2% in the general adult population. Despite this high incidence, there is a limited …

Background Mitral valve prolapse (MVP) is a common heart valve disease, the most frequent
indication for valve repair or replacement. MVP is characterized by excess extracellular …

Introduction: Mitral valve prolapse (MVP) is the most common cause of primary mitral
regurgitation and is estimated to affect between 1-3% of the general population. A subset of …

Mitral valve prolapse (MVP) is the most frequent valvular abnormality, associated with
various degrees of incompetence and sequelae including heart failure and sudden death …

Mitral valve prolapse (MVP) affects 1 in 40 people and is the most common indication for
mitral valve surgery. MVP can cause arrhythmias, heart failure, and sudden cardiac death …

Nonsyndromic Mitral valve prolapse (MVP) is a common degenerative valvular heart
disease with severe health consequences, including arrhythmia, heart failure and sudden …